Find Clinical Trials
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment with conditional titration based on the blood pressure control, in patients with uncontrolled essential hypertension after 1 month of Amlodipine 5 mg run-in treatment. An international, randomized, double-blind, multicenter controlled study.
Servier Protocol Code:
CL3-05520-006
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2012-001690-84
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Hypertension
- AMLODIPINE
- INDAPAMIDE
- S005520
Other study id numbers
Other identification numbers the study may be known by.
- CL3-05520-006